Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation

26Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Endogenous oncogenic Kras induces a highly penetrant acute T-cell lymphoblastic leukemia/lymphoma (T-ALL). Results: Up-regulation of NOTCH1 signaling, through either overexpression of surface NOTCH1 or acquired gain-of-function mutations, is involved in both T-ALL initiation and progression. Conclusion: Notch1 mutations contribute to leukemogenic transformation of normal T-cells. Significance: Our data provide a rationale to target both NOTCH1 and RAS signaling for T-ALL treatment. © 2013 by The American Society.

Cite

CITATION STYLE

APA

Kong, G., Du, J., Liu, Y., Meline, B., Chang, Y. I., Ranheim, E. A., … Zhang, J. (2013). Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation. Journal of Biological Chemistry, 288(25), 18219–18227. https://doi.org/10.1074/jbc.M113.475376

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free